P05.03 EFFECT OF COMBINED THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE (TMZ) IN PEDIATRIC MALIGNANT GLIOMAS (MG)

METHOD: There were 19 pts with MG, who enrolled in the study from May 2010 till March 2014 (10 boys and 9 girls), median age 9 yrs (range, 3-17 yrs). 15 pts (79%) were with glioblastoma (GB), 4 (21%) - anaplastic astrocytoma (AA). In 16 pts the tumor was localized supratentorial (84.21%), in 3 - inf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Geludkova, O.G., Borodina, I.D., Melikian, A.G., Kushel, Y.V., Shishkina, L.V., Rizhova, M.V., Gorbatih, S.V., Popov, V.E., Pavlova, E.V., Scherbenko, O.I.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185507/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.161
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars